P Narayana Reddy

P Narayana Reddy

Associate Professor

Education

Ph. D.

Dr. P. Narayana Reddy obtained his MSc. degree in organic chemistry from Sri Venkateswara University, India. He carried out his doctoral research in organic synthesis at Indian Institute of Chemical Technology (CSIR-IICT) . He worked as postdoctoral fellow at Sejong University, South Korea and Research Scientist at Piramal healthcare Ltd, Chennai. Currently he is working as an Associate Professor in the Department of chemistry at School of Science, GITAM Deemed to be University, Hyderabad.

Research Publications

  • Design, synthesis, and in silico studies of pyrazine-based derivatives as potential antitubercular agents. Madala Ramesh, Pedavenkatagari Narayana Reddy*, Pannala Padmaja, Kalpesh R. Patil, Rahul H. Pawra, V. Saritha Rani, Vinod G. Ugale* Journal of Molecular Structure, 2025, 139784.
  • A Brief review on the synthesis of 4H-Chromene-Embedded heterocycles; Nissi Sharon, Pannala Padmaja, Pedavenkatagari Narayana Reddy*; Chemistry Select, 2024, 29, e202400565
  • Development of novel 9H-carbazole-4H-chromene hybrids as dual cholinesterase inhibitors for the treatment of Alzheimer's disease. Nissi Sharon, Vinod G. Ugale*, Pannala Padmaja, Deepak Lokwani, Chandradeep Salunkhe, Padmaja Shete, Pedavenkatagari Narayana Reddy*, Prasad P. Kulkarni*, Molecular Diversity, 2024,
  • Molecular hybridization-based design, PASE three-component synthesis, antiproliferative activity and molecular modelling studies of N,N-dimethylaminophenyl substituted 5H-chromeno[2,3-b]pyridine analogs; Pedavenkatagari Narayana Reddy,* Nissi Sharon, Pannala Padmaja, Vinod G. Ugale, P. Deepak Lokwani, Shirish jain, Pragati, Anjali, Journal of Molecular Structure, 2023, 1286, 135589.
  • Design, synthesis and pharmacological evaluation of [1,3]dioxolo-chromeno[2,3-b]pyridines as antiseizure agents, Visarapu Malathi, Nissi Sharon, Pannala Padmaja, Deepak Lokwani, Saurabh Khadse, Prashant Chaudhari, Pedavenkatagari Narayana Reddy,* Vinod G. Ugale*, Molecular Diversity, 2022, 27, 1809-1827.

Expertise

  • Check Icon Synthesis of novel heterocyclic compounds and evaluation of their biological activities
  • Check Icon Development of new synthetic methodology through green processes
  • Check Icon Total synthesis of natural products having biological importance
  • Check Icon Rational drug design and library screening
  • Check Icon Process development of reaction intermediates, APIs

Authored Books

  • Check Icon Advances in Organic Synthesis, 2020, 273-310.
  • Check Icon Encyclopedia of Ionic Liquids, Springer, 2019.
Scroll to top